Parkinson’s Treatment Breakthrough: Novel Drug Amplifies Levodopa Results With Fewer Complications
See what tavapadon’s Phase 3 trial really showed about added levodopa “on” time—and why this promising pill is not yet available.
See what tavapadon’s Phase 3 trial really showed about added levodopa “on” time—and why this promising pill is not yet available.
Find free local or online Parkinson’s support groups through the Parkinson’s Foundation or APDA—search by zip code to locate meetings, classes, and caregiver resources.
Find FDA-approved Parkinson’s treatments, clinical trials, safety alerts, and official resources from NIH, Parkinson’s Foundation, and ClinicalTrials.gov.
Understand a new dopamine agonist coming soon, a vitamin B6 alert for current patients, and emerging therapies that may slow disease progression.
Most Parkinson’s assistance programs run indefinitely, but promotional co-pay cards and insurance changes create real deadlines—here’s how to plan ahead.
Parkinson’s treatment policies change frequently, affecting medication access and specialized care coverage with real legal and practical consequences.
Start planning your Parkinson’s treatment now—building your care team and understanding your options prevents crisis decisions later.
FDA approvals and clinical trials show real progress in Parkinson’s symptom management, but the data reveal modest advances, not transformative breakthroughs.
Parkinson’s treatment costs vary dramatically by medication class, while newer drugs promise benefits that clinical trials haven’t always delivered.
Where you live in America increasingly determines how fast you can see a Parkinson’s specialist and which treatments you can afford.